Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AZTR | US
0
0%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.61
0.62
0.63
0.59
Azitra Inc a pre-clinical biopharmaceutical company focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12 a genetically modified strain of S. epidermidis for treating Netherton syndrome a skin disease; ATR-04 a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01 an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris a skin disease. The company was incorporated in 2014 and is based in Branford Connecticut.
View LessLow Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
44.0%1 month
45.4%3 months
453.8%6 months
353.8%0.01
-
2.42
0.42
0.19
-0.39
10.02
-
-10.12M
4.65M
4.65M
-
-35.47K
-
-95.60
-222.30
0.78
3.18
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.17
Range1M
0.17
Range3M
11.54
Rel. volume
1.43
Price X volume
189.34K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
180 Life Sciences Corp | ATNF | Biotechnology | 4.97 | 5.10M | -1.19% | n/a | -105.81% |
Molecular Templates Inc | MTEM | Biotechnology | 0.75 | 4.94M | 0.00% | n/a | 155.07% |
QLGN | QLGN | Biotechnology | 0.1825 | 4.93M | 9.15% | n/a | -39.04% |
Enveric Biosciences Inc | ENVB | Biotechnology | 0.538 | 4.80M | 20.33% | n/a | 0.00% |
CNS PHARMACEUTICALS INC | CNSP | Biotechnology | 0.146 | 4.69M | 19.67% | n/a | -2.87% |
ADTX | ADTX | Biotechnology | 1.09 | 4.60M | 3.81% | n/a | 122.46% |
Pasithea Therapeutics Corp. Common Stock | KTTA | Biotechnology | 4.39 | 4.59M | 1.62% | n/a | 0.00% |
Hepion Pharmaceuticals Inc | HEPA | Biotechnology | 0.7501 | 4.35M | -8.30% | n/a | 4.33% |
AquaBounty Technologies Inc | AQB | Biotechnology | 1.1 | 4.25M | -8.33% | n/a | 10.41% |
Titan Pharmaceuticals Inc | TTNP | Biotechnology | 4.58 | 4.19M | -4.38% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.39 | 0.53 | Cheaper |
Ent. to Revenue | 10.02 | 3,967.00 | Cheaper |
PE Ratio | 0.01 | 41.03 | Cheaper |
Price to Book | 2.42 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 453.83 | 72.80 | Riskier |
Debt to Equity | 0.42 | -1.23 | Expensive |
Debt to Assets | 0.19 | 0.25 | Cheaper |
Market Cap | 4.65M | 3.66B | Emerging |